Clinical Trials Logo

Clinical Trial Summary

Doctors are studying an investigational treatment to be used during the vertebroplasty procedure when treating vertebral compression fractures (spine fractures) that may help to reduce pain and restore mobility. If one has experienced back pain for at least 4 weeks but not longer than 1 year, he/she may be eligible to participate.

The purpose of this protocol is to describe the methods for the clinical evaluation of Cortoss for vertebroplasty in patients with painful osteoporotic compression fractures.

Eligible patients with painful osteoporotic compression fractures of the spine are divided into two groups. Each enrolled patient will have the vertebroplasty procedure; however one group of patients will have the vertebroplasty procedure using polymethylmethacrylate [PMMA] (a Food and Drug Administration [FDA]-approved bone cement) and the other group of patients will have the vertebroplasty procedure using a relatively new (investigational) biomaterial called Cortoss.


Clinical Trial Description

This is a prospective, multi-center randomized, controlled study designed to evaluate the safety and effectiveness of Cortoss® Synthetic Cortical Bone Void Filler in vertebral augmentation using the percutaneous vertebroplasty technique. Study eligible patients with painful osteoporotic compression fractures will be randomized (2:1) to vertebroplasty with Cortoss (treatment group) or PMMA (control group), respectively. Patients will not be told which treatment they will receive (single blind study design). Safety and effectiveness will be determined by comparing the success rate of the treatment group to the success rate of the control group. Secondary endpoints will include Quality of Life, Patient satisfaction, evaluation of the patient's pain and function post-operatively compared to baseline, and maintenance of vertebral body height and alignment.

For the purposes of this study, vertebral augmentation, or vertebroplasty, is defined as a minimally invasive procedure utilizing manual instruments and radiological guidance to deliver an in-situ polymerizable material to stabilize a collapsed or fractured vertebral body. The goal is to alleviate pain caused by the fracture and enhance or prevent further deterioration of function.

This multi-center study will evaluate Cortoss for the augmentation of one or two vertebra(e), fractured as a result of osteoporosis, located between (and including) the levels of the sixth thoracic and the fifth lumbar vertebrae. A total of 243 patients will be enrolled at up to 19 sites. All subjects must have radiographic evidence of a vertebral body fracture due to osteoporosis. After complying with all eligibility criteria, subjects will sign an informed consent document and will be randomized into vertebroplasty treatment with Cortoss or PMMA (1:1 ratio). Patients will be followed for at least 24 months and recruitment is expected to take between 9 and 12 months. Visits and assessments are planned according to the time and events schedule. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT00290862
Study type Interventional
Source Orthovita d/b/a Stryker
Contact
Status Unknown status
Phase N/A
Start date September 2004
Completion date March 2009

See also
  Status Clinical Trial Phase
Terminated NCT02931266 - PASS MIS® Post-market Clinical Follow-up
Completed NCT02566655 - Clinical Trial of Intravenous Infusion of Fucosylated Bone Marrow Mesenchyme Cells in Patients With Osteoporosis Phase 1
Completed NCT04956588 - Evaluation of the Safety and Efficacy of Smart Orthopedic Minimally Invasive Surgical Systems for Spinal Surgery Phase 3
Completed NCT04201678 - Effectiveness of Erector Spinae Block in Kyphoplasty N/A
Completed NCT02931279 - PASS OCT® Post-market Clinical Follow-up
Completed NCT02950532 - Posterior Ligament Complex Assessment Without Magnetic Resonance Image in Thoracolumbar Fractures
Completed NCT02839057 - Survival After Surgical Treatment of Axis Fractures in Elderly N/A
Completed NCT02719340 - Short Segment Fixation in Thoracolumbar Osteoporotic Fracture N/A
Completed NCT02826889 - Assessing the Diagnostic Accuracy of Corrected Flow Time (FTc) and Pleth Variability Index (PVI) as Predictors of Fluid Responsiveness in Patients in the Prone Position Using the Jackson Table N/A
Recruiting NCT02768675 - Intra-operative Assessment of the Intellirod LOADPRO Spinal Rod Strain Sensor for Use During Kyphotic Corrective Surgery N/A
Completed NCT00211237 - CAFE Study - Cancer Patient Fracture Evaluation N/A
Recruiting NCT02784782 - Thoracolumbar Burstfractures, Orthesis or No Orthesis Phase 4
Withdrawn NCT04325165 - DBS of PPN to Improve Walking in Chronic SCI Patients N/A
Completed NCT01123512 - The Kiva® System as a Vertebral Augmentation Treatment Phase 3
Withdrawn NCT00594321 - Evaluation of Fracture Fixation With Energy and Cement in Tumors of the Spine N/A
Not yet recruiting NCT02603874 - The Development of a Vertebra Localizing Aid Medical Device N/A
Completed NCT01761084 - Build Better Bones With Exercise N/A
Completed NCT02840695 - Effect of Biological Disease Modifying Anti Rheumatic Drug (bDMARD) Treatment on Spinal Fracture Incidence in Patients With Ankylosing Spondylitis (AS) N/A
Completed NCT02657265 - SpineJack® Versus Conservative Treatment Study (SPICO Study) N/A
Active, not recruiting NCT02789774 - Uppsala Study on Odontoid Fracture Treatment in the Elderly N/A